choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Hycamtin

Hycamtin Newsletter
  • Tarlatamab and the ES-SCLC Treatment Landscape: Managing AEs and Educating Patients 19 Jun 2025 23:08 GMT

    … research, and professor of medicine; Michelle Sittig, RN, … chemotherapy. Prior to those trials, patients received 6 cycles … second-line setting, topotecan [Hycamtin] is the historical agent … randomized trial where after the standard induction treatment with …

  • Which critical medicines are in short supply in the European Union? 11 Mar 2025 23:20 GMT

    … urge doctors to transition their patients to other brands. Seven cancer drugs … seven drugs used to treat various types of cancers, including hycamtin, methotrexate … , leaving the medicine in short supply, though other treatments are available. Limited …

  • New Strategies in SCLC and DLBCL Are Transforming the Treatment Landscape 27 Nov 2024 23:21 GMT

    … topotecan (Hycamtin; Pfizer), or alternatively enrollment in clinical trials investigating other … (Hansizhuang; Shanghai Henlius Biotech) and antibody drug conjugates such as ifinatamab … more than 1500 clinical trials focusing on treatment for DLBCL have been …

  • Introducing Tarlatamab-dlle: A New Era in Oncology Treatment 22 Oct 2024 13:22 GMT

    … initiation of treatment. In the DeLLphi-301 trial findings, … tested in clinical trials in which patients … lurbinectedin (Zepzelca; Jazz Pharmaceuticals, PharmaMar), topotecan (Hycamtin; Pfizer), or … Clinics Investigational Drug Service at Keck Medicine of USC …

  • Obrixtamig Plus Topotecan Shows Tolerability, Efficacy in Advanced ES-SCLC 04 Jul 2025 20:15 GMT

    The addition of topotecan (Hycamtin) to obrixtamig (BI 764532 … Early Clinical Trial Unit and of the Trial Management National … investigation of the combination treatment.” Patients with histologically or … Efficacy data from the trial revealed that among 23 …

  • Avutometinib Earns FDA Orphan Drug Designation in Recurrent Ovarian Cancer 06 Mar 2024 17:41 GMT

    … clinical trial to deliver this new combination treatment to … and 15; IV topotecan (Hycamtin) at 4 mg/ … compression, a history of medically significant rhabdomyolysis, concurrent … Oncology receives orphan drug designation from FDA for avutometinib alone …

  • Could Your Patients Benefit? New Trials in Lung Cancer 20 Sep 2023 13:59 GMT

    … . The platinum drugs will be dropped … treatment. Centers across 10 states started recruiting 474 participants for the trial … lurbinectedin (Zepzelca), topotecan (Hycamtin), or amrubicin (Calsed) … National Library of Medicine (online at clinicaltrials …

  • Will Sandoz’s products boost Samil Pharmaceutical’s sales? 27 Jun 2023 05:12 GMT

    Samil Pharmaceutical, a Korean drugmaker, is expanding its business in … , anticancer drug Hycamtin, cardiovascular drug Ampibesyl, anti-nausea drug Zofran, antihistamine drug Zaditen, hormone drug Parlodel …

  • What to know about leukemia medication 28 Feb 2023 18:43 GMT

    … (VePesid) topotecan (Hycamtin) Learn about oral chemotherapy drugs. Histone deacetylase inhibitors … chronic myeloid leukemia. Leukemia medications aim to destroy cancer cells … or immunotherapy drugs. Doctors will decide the best course of treatment based on …

  • Lurbinectedin/Pembrolizumab Shows Significant Activity in Relapsed SCLC 25 Apr 2025 19:05 GMT

    … following 12 months of treatment. The median progression- … , MSc, from the Medical Oncology Department at Hospital … Hycamtin; 44.4%) and irinotecan (Camptosar; 33.3%) as third-line treatment … portion of the trial, any-grade treatment-emergent adverse effects …

Satisfied with the content?

Continue to create your account.